Comparative Study of KL-6, Surfactant Protein-A, Surfactant Protein-D, and Monocyte Chemoattractant Protein-1 as Serum Markers for Interstitial Lung Diseases
Top Cited Papers
- 1 February 2002
- journal article
- research article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 165 (3) , 378-381
- https://doi.org/10.1164/ajrccm.165.3.2107134
Abstract
KL-6, surfactant protein (SP)-A, SP-D, and monocyte chemoattractant protein-1 (MCP-1) are reported to be sensitive markers for interstitial lung diseases (ILD). However, each marker has been studied independently. The aim of this study was a comparative analysis of the diagnostic values of these markers. Subjects consisted of 33 patients with ILD (21 cases of idiopathic pulmonary fibrosis and 12 associated with collagen vascular diseases) and 82 control subjects (12 cases of bacterial pneumonia and 70 healthy volunteers). Receiver operating characteristic curves revealed that KL-6 was superior to the other markers. The cut-off levels for these markers that resulted in the highest diagnostic accuracy were determined to be 465 U/ml for KL-6, 48.2 ng/ml for SP-A, 116 ng/ml for SP-D, and 1080 pg/ml for MCP-1. The sensitivity, specificity, and diagnostic accuracy were 93.9%, 96.3%, and 95.7% for KL-6; 81.8%, 86.6%, and 85.2% for SP-A; 69.7%, 95.1%, and 87.8% for SP-D; and 51.5%, 92.7%, and 80.9% for MCP-1; respectively. The serum levels of SP-A and SP-D, but not of KL-6, were significantly higher in patients with bacterial pneumonia than in healthy volunteers. These results suggest that of the markers studied, KL-6 is the best serum marker for ILD.Keywords
This publication has 20 references indexed in Scilit:
- Serum Levels of Surfactant Proteins A and D Are Useful Biomarkers for Interstitial Lung Disease in Patients with Progressive Systemic SclerosisAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Circulating KL-6 Predicts the Outcome of Rapidly Progressive Idiopathic Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Serum and Bronchoalveolar Fluid KL-6 Levels in Patients with Pulmonary Alveolar ProteinosisAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Comparative studies of circulating KL-6, type III procollagen N-terminal peptide and type IV collagen 7S in patients with interstitial pneumonitis and alveolar pneumoniaRespiratory Medicine, 1997
- Pulmonary surfactant protein D in sera and bronchoalveolar lavage fluids.American Journal of Respiratory and Critical Care Medicine, 1995
- KL-6, a Mucin-like Glycoprotein, in Bronchoalveolar Lavage Fluid from Patients with Interstitial Lung DiseaseAmerican Review of Respiratory Disease, 1993
- Elevated Levels of Lung Surfactant Protein A in Sera from Patients with Idiopathic Pulmonary Fibrosis and Pulmonary Alveolar ProteinosisAmerican Review of Respiratory Disease, 1993
- Circulating Antigen KL-6 and Lactate Dehydrogenase for Monitoring Irradiated Patients with Lung CancerChest, 1992
- Alveolitis and Collapse in the Pathogenesis of Pulmonary FibrosisAmerican Review of Respiratory Disease, 1989
- New Serum Indicator of Interstitial Pneumonitis ActivityChest, 1989